RBC Capital lowered the firm’s price target on Corteva to $56 from $61 but keeps an Outperform rating on the shares after its Q3 results. The company offers a strong new product pipeline and prices for value, along with significant non-market dependent cost and royalty reduction opportunities, the analyst tells investors in a research note. The firm is reducing its growth outlook for 2024 and 2025 growth however due to lower Ag sentiment, RBC added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CTVA:
- Corteva price target lowered to $60 from $65 at Canaccord
- Corteva price target lowered to $62 from $66 at KeyBanc
- Corteva post-earnings selloff overdone, says Deutsche Bank
- Corteva reaffirms 2023 operating EPS view $2.50-$2.70, consensus $2.81
- Corteva Reports Third Quarter and Year-to-Date 2023 Results, Affirms Full-Year Net Sales and Earnings Guidance